Results 191 to 200 of about 1,203 (200)

ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata

Clinical Microbiology and Infection, 2022
Aina Mesquida, Judith Díaz-García, Patricia Carmen Muñoz García   +2 more
exaly  

Ibrexafungerp bei akuter vulvovaginaler Candidose effektiv und sicher

Geburtshilfe und Frauenheilkunde, 2022
openaire   +1 more source

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies

Journal of Fungi (Basel, Switzerland), 2021
Olga Rivero-Menendez, Ana Alastruey-Izquierdo   +1 more
exaly  

Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis

Annals of Pharmacotherapy, 2023
Kylie Barnes
exaly  

Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis.

American family physician, 2022
Kelsea, Woolfolk, Jonathan, Hughes
openaire   +1 more source

Ibrexafungerp. 1,3-Beta-Glucan synthase inhibitor, Triterpenoid antifungal agent

Drugs of the Future, 2019
null Thakare, R., null Dasgupta, A., null Chopra, S.   +2 more
openaire   +1 more source

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

Antibiotics, 2020
Maiken Cavling Arendrup, Sudha Chaturvedi, Elizabeth L Berkow   +2 more
exaly  

Estimated time to relief from vulvovaginal symptoms with ibrexafungerp: patient reported data from the VANISH studies

American Journal of Obstetrics and Gynecology, 2023
Azie N, King T, Sanchez S, Angulo D
openaire   +1 more source

Ibrexafungerp (Brexafemme) for vulvovaginal candidiasis.

The Medical letter on drugs and therapeutics, 2021
openaire   +1 more source

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

BJOG: an International Journal of Obstetrics and Gynaecology, 2022
exaly